Nuvaira
PrivateLast Round
Early Stage
VC
Mar 4, 2026
Total Funding Raised
$150.98M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nuvaira is a medical technology company that develops a novel catheter-based device aimed at improving outcomes for patients with obstructive lung diseases by treating overactive airway nerves.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuvaira Comparables
Compare Nuvaira with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Galvanize Therapeutics | 86% | |
| CSA Medical | 84% | |
| Apreo Health | 79% | |
Nuvaira Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Mar 4, 2026 | ||||
| Seed | Aug 25, 2025 | ||||
| VC Round | Nov 28, 2023 | ||||
| Series E | Feb 11, 2019 | ||||
| Series D | Apr 3, 2014 | ||||
Series C | Feb 11, 2013 |
Nuvaira Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vertex Ventures HC | Series E |
| Lightstone Ventures | Series E |
| Split Rock Partners | Series C, Series B, Series A, Series D, Series E |
| U.S. Venture Partners | Series E |
| Richard King Mellon Foundation | Series E |
| Versant Ventures | Series C, Series B, Series A, Series D, Series E |
| Advanced Technology Ventures | Series C, Series A, Series D, Series E, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors grew 137% MoM, reaching 1.7K.
- Mar 4, 2026
Raised $36M in an early stage VC round.
Nuvaira Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nuvaira's valuation, stock price, and market status.